Ufp Technologies (UFPT) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.26% |
| Dec 31, 2025 | 33.31% |
| Sep 30, 2025 | 40.54% |
| Jun 30, 2025 | 49.27% |
| Mar 31, 2025 | 34.59% |
| Dec 31, 2024 | 23.17% |
| Sep 30, 2024 | 23.73% |
| Jun 30, 2024 | 24.13% |
| Mar 31, 2024 | 27.73% |
| Dec 31, 2023 | 21.35% |
| Sep 30, 2023 | 23.12% |
| Jun 30, 2023 | 24.39% |
| Mar 31, 2023 | 40.53% |
| Dec 31, 2022 | 25.54% |
| Sep 30, 2022 | 63.06% |
| Jun 30, 2022 | 27.69% |
| Mar 31, 2022 | 17.48% |
| Dec 31, 2021 | 16.64% |
| Sep 30, 2021 | 7.26% |
| Jun 30, 2021 | 11.51% |
| Mar 31, 2021 | 31.10% |
| Dec 31, 2020 | 20.01% |
| Sep 30, 2020 | 8.45% |
| Jun 30, 2020 | 0.40% |
| Mar 31, 2020 | 18.67% |
| Dec 31, 2019 | 29.75% |
| Sep 30, 2019 | 22.25% |
| Jun 30, 2019 | 19.84% |
| Mar 31, 2019 | 12.61% |
| Dec 31, 2018 | 5.48% |
| Sep 30, 2018 | 7.44% |
| Jun 30, 2018 | 6.00% |
| Mar 31, 2018 | -2.63% |
| Dec 31, 2017 | -3.26% |
| Sep 30, 2017 | -8.17% |
| Jun 30, 2017 | -0.87% |
| Mar 31, 2017 | -1.56% |
| Dec 31, 2016 | -13.07% |
| Sep 30, 2016 | 1.85% |
| Jun 30, 2016 | 0.24% |
| Mar 31, 2016 | -13.38% |
| Dec 31, 2015 | -11.51% |
| Sep 30, 2015 | -3.37% |
| Jun 30, 2015 | -0.22% |